Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1810 (LINC01810) is a member of the long intergenic non-coding RNA (lincRNA) class, defined as autonomously transcribed non-protein-coding RNAs longer than 200 nucleotides that do not overlap protein-coding loci[1][5]. LincRNAs, including LINC01810, are thought to regulate gene expression and chromatin state, often with tissue-specific patterns, and may modulate neighboring gene activity via diverse regulatory mechanisms[5]. Although functional details of LINC01810 itself remain uncharacterized, lincRNAs as a class are implicated in gene regulation, epigenetic control, and disease, especially cancer[3][5]. No experimentally established roles, disease associations, or therapeutic interventions specific to LINC01810 have yet been published in the scientific literature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1810 (LINC01810).